US Patent 11203640 Checkpoint inhibitor bispecific antibodies

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112036400

Patent Inventor Names

Yiwen Li0

Igor Edmondo Paolo D'Angelo0

Michael Dewain Kalos0

Yang Shen0

Dale Lincoln Ludwig0

Gregory D Plowman0

Date of Patent

December 21, 2021

Patent Application Number

160299790

Date Filed

July 9, 2018

Patent Primary Examiner

‌

Brad Duffy

Patent abstract

The present invention relates to antibodies that are heterodimeric and bind human PD-L1 and human PD-1, and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11203640 Checkpoint inhibitor bispecific antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API